Browse by UCL people
Group by: Type | Date
Number of items: 28.
2024
Fabiane, SM;
Chiang, CY;
Meredith, SK;
Gurumurthy, M;
Bayissa, A;
Nunn, AJ;
Goodall, RL;
(2024)
Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis.
Tropical Medicine and Infectious Disease
, 9
(9)
, Article 211. 10.3390/tropicalmed9090211.
|
Goodall, Ruth L;
Nunn, Andrew J;
Meredith, Sarah K;
Bayissa, Adamu;
Bhatnagar, Anuj K;
Chiang, Chen-Yuan;
Conradie, Francesca;
... STREAM study collaborators; + view all
(2024)
Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
The Lancet Respiratory Medicine
10.1016/S2213-2600(24)00186-3.
(In press).
|
Hughes, Gareth;
Young, William J;
Bern, Henry;
Crook, Angela;
Lambiase, Pier D;
Goodall, Ruth L;
Nunn, Andrew J;
(2024)
T-wave morphology abnormalities in the STREAM stage 1 trial.
Expert Opinion on Drug Safety
, 23
(4)
pp. 469-476.
10.1080/14740338.2024.2322116.
|
2022
Kokebu, DM;
Ahmed, S;
Moodliar, R;
Chiang, C-Y;
Torrea, G;
Van Deun, A;
Goodall, RL;
... Nunn, AJ; + view all
(2022)
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB.
International Journal of Tuberculosis and Lung Disease
, 26
(8)
pp. 753-759.
10.5588/ijtld.22.0073.
|
Rosu, Laura;
Madan, Jason J;
Tomeny, Ewan M;
Muniyandi, Malaisamy;
Nidoi, Jasper;
Girma, Mamo;
Vilc, Valentina;
... STREAM, Study Health Economic Evaluation Collaborators; + view all
(2022)
Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial.
The Lancet Global Health
10.1016/S2214-109X(22)00498-3.
(In press).
|
2021
Ejo, M;
Van Deun, A;
Nunn, A;
Meredith, S;
Ahmed, S;
Dalai, D;
Tumenbayar, O;
... Torrea, G; + view all
(2021)
Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial.
The International Journal of Tuberculosis and Lung Disease
, 25
(10)
pp. 839-845.
10.5588/ijtld.21.0212.
|
2020
Phillips, PPJ;
Van Deun, A;
Ahmed, S;
Goodall, RL;
Meredith, SK;
Conradie, F;
Chiang, C-Y;
... Nunn, AJ; + view all
(2020)
Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial.
BMC Medicine
, 18
, Article 314. 10.1186/s12916-020-01770-z.
|
2019
Nunn, AJ;
Phillips, PPJ;
Meredith, SK;
Chiang, C-Y;
Conradie, F;
Dalai, D;
van Deun, A;
... STREAM Study Collaborators, .; + view all
(2019)
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.
The New England Journal of Medicine
, 380
(13)
pp. 1201-1213.
10.1056/NEJMoa1811867.
|
Tweed, CD;
Crook, AM;
Dawson, R;
Diacon, AH;
McHugh, TD;
Mendel, CM;
Meredith, SK;
... Gillespie, SH; + view all
(2019)
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
BMC Pulmonary Medicine
, 19
(1)
, Article 152. 10.1186/s12890-019-0907-6.
|
2018
Murphy, ME;
Wills, GH;
Murthy, S;
Louw, C;
Bateson, ALC;
Hunt, RD;
McHugh, TD;
... REMoxTB consortium, .; + view all
(2018)
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study.
BMC Medicine
, 16
(189)
10.1186/s12916-018-1169-5.
|
Stenning, SP;
Cragg, WJ;
Joffe, N;
Diaz-Montana, C;
Choudhury, R;
Sydes, MR;
Meredith, S;
(2018)
Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study.
Clinical Trials
, 15
(6)
pp. 600-609.
10.1177/1740774518793379.
|
Tweed, CD;
Crook, AM;
Amukoye, EI;
Dawson, R;
Diacon, AH;
Hanekom, M;
McHugh, TD;
... Gillespie, SH; + view all
(2018)
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
BMC Infectious Diseases
, 18
, Article 317. 10.1186/s12879-018-3230-6.
|
Tweed, CD;
Wills, GH;
Crook, AM;
Dawson, R;
Diacon, AH;
Louw, CE;
McHugh, TD;
... Gillespie, SH; + view all
(2018)
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
BMC Medicine
, 16
(1)
, Article 46. 10.1186/s12916-018-1033-7.
|
2017
Murphy, ME;
Phillips, PJ;
Mendel, CM;
Bongard, E;
Bateson, AL;
Hunt, R;
Murthy, S;
... Lipman, M; + view all
(2017)
Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis.
BMC Medicine
, 15
, Article 192. 10.1186/s12916-017-0947-9.
|
2016
Cho, G;
Anie, KA;
Buckton, J;
Kiilu, P;
Layton, M;
Alexander, L;
Hemmaway, C;
... Meredith, S; + view all
(2016)
SWIM (sickle with ibuprofen and morphine) randomised controlled trial fails to recruit: lessons learnt.
BMJ OPEN
, 6
(6)
10.1136/bmjopen-2016-011276.
|
Tweed, CD;
Wills, G;
Crook, AM;
Meredith, SK;
Nunn, AJ;
Mendel, CM;
Murray, SR;
... Gillespie, SH; + view all
(2016)
Liver Function Tests During Tuberculosis Treatment And The Implications On Monitoring For Hepatotoxicity.
Presented at: British Thoracic Society Winter Meeting 2016, London, UK.
|
Tweed, CD;
Wills, G;
Crook, AM;
Meredith, SK;
Nunn, AJ;
Mendel, CM;
Murray, SR;
... Gillespie, SH; + view all
(2016)
Using adverse events in a tuberculosis trial to describe the tolerability of standard therapy.
Presented at: British Thoracic Society Winter Meeting 2016, London, UK.
|
2015
Jairath, V;
Kahan, BC;
Gray, A;
Dore, CJ;
Mora, A;
James, MW;
Stanley, AJ;
... Murphy, MF; + view all
(2015)
Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.
The Lancet
, 386
(9989)
pp. 137-144.
10.1016/S0140-6736(14)61999-1.
|
Sydes, MR;
Johnson, AL;
Meredith, SK;
Rauchenberger, M;
South, A;
Parmar, MK;
(2015)
Sharing data from clinical trials: the rationale for a controlled access approach.
Trials
, 16
(1)
, Article 104. 10.1186/s13063-015-0604-6.
|
2014
Brueton, VC;
Stevenson, F;
Vale, CL;
(2014)
Use of strategies to improve retention in primary care randomised trials: a qualitative study with in-depth interviews.
BMJ Open
, 4
(1)
, Article e003835. 10.1136/bmjopen-2013-003835.
|
Brueton, VC;
Tierney, JF;
Stenning, S;
Meredith, S;
Harding, S;
Nazareth, I;
Rait, G;
(2014)
Strategies to improve retention in randomised trials: a Cochrane systematic review and meta-analysis.
BMJ Open
, 4
(2)
, Article e003821. 10.1136/bmjopen-2013-003821.
|
Gillespie, SH;
Crook, AM;
McHugh, TD;
Mendel, CM;
Meredith, SK;
Murray, SR;
Pappas, F;
... REMoxTB, Consortium; + view all
(2014)
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
New England Journal of Medicine
, 371
(17)
pp. 1577-1587.
10.1056/NEJMoa1407426.
|
Nunn, AJ;
Rusen, ID;
Van Deun, A;
Torrea, G;
Phillips, PJP;
Chiang, C-Y;
Squire, SB;
... Meredith, SK; + view all
(2014)
The Evaluation of a Standardised Treatment Regimen of anti-Tuberculosis Drugs for Patients with MDR-TB (STREAM): study protocol for a randomised controlled trial.
Trials
, 15
(Septem)
, Article 353. 10.1186/1745-6215-15-353.
|
2013
Brueton, VC;
Tierney, J;
Stenning, S;
Harding, S;
Meredith, S;
Nazareth, I;
Rait, G;
(2013)
Strategies to improve retention in randomised trials.
Cochrane Database Syst Rev
, 12
, Article MR000032. 10.1002/14651858.MR000032.pub2.
|
Jairath, V;
Kahan, BC;
Gray, A;
Doré, CJ;
Mora, A;
Dyer, C;
Stokes, EA;
... Murphy, MF; + view all
(2013)
Restrictive vs Liberal Blood Transfusion for Acute Upper Gastrointestinal Bleeding: Rationale and Protocol for a Cluster Randomized Feasibility Trial.
Transfus Med Rev
, 27
(3)
146 - 153.
10.1016/j.tmrv.2013.04.001.
|
2011
Brueton, V;
Tierney, J;
Stenning, S;
Nazareth, I;
Meredith, S;
Harding, S;
Rait, G;
(2011)
Strategies to reduce attrition in randomised trials.
Trials
, 12 Sup
, Article A128. 10.1186/1745-6215-12-S1-A128.
|
Thomas, KS;
Dean, T;
O'Leary, C;
Sach, TH;
Koller, K;
Frost, A;
Williams, HC;
(2011)
A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children.
PLoS Medicine
, 8
(2)
, Article e1000395. 10.1371/journal.pmed.1000395.
|
2007
Vickers, MR;
MacLennan, AH;
Lawton, B;
Ford, D;
Martin, J;
Meredith, SK;
DeStavola, BL;
... WISDOM Team; + view all
(2007)
Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.
BRIT MED J
, 335
(7613)
239 - +.
10.1136/bmj.39266.425069.AD.
|